The HHS Office of Inspector General (OIG) has released a report entitled “Marketing Materials for Medicare Prescription Drug Plans.” Among other things, the OIG found that CMS’s oversight of marketing materials for stand-alone Medicare prescription drug plans is limited, the agency’s model documents are not consistent with its guidelines, and 85% of marketing materials failed to meet at least one element of CMS’s guidelines.
